Table 1. Comparison of Transplant and... | American Society of Hematology

Table 1.

Comparison of Transplant and Nontransplant Cohorts

Variable	Treatment for CML				P
Variable	No.	Transplant	No.	Hydroxyurea or Interferon	P
No. of patients		548		196
Age, median (range) yr	548	35 (15-54)	196	41 (15-55)	<.001
Male sex, No. (%)	548	331 (60)	196	119 (61)	.41
WBC at Dx, median (range) N × 10⁹/L	548	140 (3-850)	196	150 (15-489)	.004
Hemoglobin at Dx, median (range), ×g/dL	479^*	12 (2-17)	196	12 (4-16)	.06
Platelets at Dx, median (range) N × 10⁹/L	489^*	419 (2-3,440)	196	412 (94-1,739)	.62
% Blasts at Dx, median (range)	400^*	1 (0-10)	196	2 (0-10)	<.0001
Spleen size at Dx, median (range) cm	466^*	3 (0-26)	196	5 (0-30)	.05
Sokal score at Dx, No. (%)	337^*		196		.48
Low risk		137 (41)		72 (37)
Intermediate risk		125 (37)		83 (42)
High risk		75 (22)		41 (21)
Year of diagnosis <1988, No. (%)	548	294 (41)	196	94 (48)	.05

Variable	Treatment for CML				P
Variable	No.	Transplant	No.	Hydroxyurea or Interferon	P
No. of patients		548		196
Age, median (range) yr	548	35 (15-54)	196	41 (15-55)	<.001
Male sex, No. (%)	548	331 (60)	196	119 (61)	.41
WBC at Dx, median (range) N × 10⁹/L	548	140 (3-850)	196	150 (15-489)	.004
Hemoglobin at Dx, median (range), ×g/dL	479^*	12 (2-17)	196	12 (4-16)	.06
Platelets at Dx, median (range) N × 10⁹/L	489^*	419 (2-3,440)	196	412 (94-1,739)	.62
% Blasts at Dx, median (range)	400^*	1 (0-10)	196	2 (0-10)	<.0001
Spleen size at Dx, median (range) cm	466^*	3 (0-26)	196	5 (0-30)	.05
Sokal score at Dx, No. (%)	337^*		196		.48
Low risk		137 (41)		72 (37)
Intermediate risk		125 (37)		83 (42)
High risk		75 (22)		41 (21)
Year of diagnosis <1988, No. (%)	548	294 (41)	196	94 (48)	.05

*Not available for all patients.

Abbreviations: WBC, white blood cell count; Dx, diagnosis.